The VTT spin-off, VitalSignum, is making a small mobile device that detects arrhythmia by measuring the patient’s ECG – available to consumers. The first production batch is being completed and will be retailed to consumers in early October. The device has been tested, with good results, on heart patients for three years at the University Hospital of...